CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
of Best Available Therapy (BAT) for treatment-resistant relapsing multiple sclerosis (MS). Participants will be randomized...
Phase 3
Houston, Texas, United States and 21 other locations
This study will evaluate if relapsing-remitting MS patients that have not had a relapse in the past year would benefit from a switch to ofat...
Phase 4
Houston, Texas, United States of America and 42 other locations
This protocol is part of a clinical study to evaluate efficacy and safety of multiple intravenous administrations of HB-adMSCs for the treat ...
Phase 2
Sugar Land, Texas, United States
This double-blind, double-dummy study will evaluate the safety and efficacy of ocrelizumab compared with fingolimod in children and adolescents with...
Phase 3
Houston, Texas, United States and 102 other locations
To compare the efficacy and safety of remibrutinib versus teriflunomide in patients with relapsing multiple sclerosis (RMS)...
Phase 3
Houston, Texas, United States and 200 other locations
The MS pilot study will assess the safety and investigate the remyelinating effects of the SetPoint System (study device) in adult patients ...
Houston, Texas, United States and 5 other locations
Clinical trials
Research sites
Resources
Legal